Validity and reliability of outcome measures to assess dysfunctional breathing: a systematic review.


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
16 Apr 2024
Historique:
received: 23 06 2023
accepted: 15 03 2024
medline: 18 4 2024
pubmed: 17 4 2024
entrez: 16 4 2024
Statut: epublish

Résumé

This study aimed to systematically review the psychometric properties of outcome measures that assess dysfunctional breathing (DB) in adults. Studies on developing and evaluating measurement properties to assess DB were included. The study investigated the empirical research published between 1990 and February 2022, with an updated search in May 2023 in the Cochrane Library database of systematic reviews and the Cochrane Central Register of Controlled Trials, the Ovid Medline (full), the Ovid Excerta Medica Database, the Ovid allied and complementary medicines database, the Ebscohost Cumulative Index to Nursing and Allied Health Literature and the Physiotherapy Evidence Database. The included studies' methodological quality was assessed using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) risk of bias checklist. Data analysis and synthesis followed the COSMIN methodology for reviews of outcome measurement instruments. Sixteen studies met the inclusion criteria, and 10 outcome measures were identified. The psychometric properties of these outcome measures were evaluated using COSMIN. The Nijmegen Questionnaire (NQ) is the only outcome measure with 'sufficient' ratings for content validity, internal consistency, reliability and construct validity. All other outcome measures did not report characteristics of content validity in the patients' group. The NQ showed high-quality evidence for validity and reliability in assessing DB. Our review suggests that using NQ to evaluate DB in people with bronchial asthma and hyperventilation syndrome is helpful. Further evaluation of the psychometric properties is needed for the remaining outcome measures before considering them for clinical use. CRD42021274960.

Identifiants

pubmed: 38626928
pii: 11/1/e001884
doi: 10.1136/bmjresp-2023-001884
pii:
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: VM and AP are authors of some of the included articles. They were not engaged in evaluating the methodological quality of these articles. They have no other competing interests. The first author (VM) article (TFBS) was included in this review; to mitigate conflict of interest and risk of bias, only CR investigated the articles related to TFBS.

Références

Heliyon. 2022 Dec 13;8(12):e12296
pubmed: 36578404
Clin Physiol Funct Imaging. 2010 Sep;30(5):349-353
pubmed: 20584032
Clin Physiol Funct Imaging. 2011 Jan;31(1):1-4
pubmed: 20735443
PLoS One. 2018 Oct 11;13(10):e0205634
pubmed: 30308070
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Asthma. 2023 Aug;60(8):1493-1502
pubmed: 36562757
Appl Psychophysiol Biofeedback. 2008 Jun;33(2):91-100
pubmed: 18320303
Int J Sports Phys Ther. 2016 Oct;11(5):803-809
pubmed: 27757292
J Clin Med. 2021 Jan 26;10(3):
pubmed: 33530621
Eur Respir Rev. 2016 Sep;25(141):287-94
pubmed: 27581828
J Asthma. 2014 Oct;51(8):839-46
pubmed: 24823322
Lancet Respir Med. 2018 Jan;6(1):19-28
pubmed: 29248433
Int J Sports Phys Ther. 2016 Dec;11(6):971-979
pubmed: 27904799
J Bras Pneumol. 2019 Feb 11;45(1):e20170347
pubmed: 30758427
Respir Med. 2011 Aug;105(8):1153-9
pubmed: 21454062
Tanaffos. 2015;14(2):121-7
pubmed: 26528366
Paediatr Respir Rev. 2015 Jan;16(1):53-61
pubmed: 25499573
J Crit Care. 2016 Aug;34:111-5
pubmed: 27288621
Appl Psychophysiol Biofeedback. 2016 Mar;41(1):111-20
pubmed: 26400252
Health Sci Rep. 2022 May 24;5(3):e661
pubmed: 35620546
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):82-9
pubmed: 18583200
J Bodyw Mov Ther. 2017 Jul;21(3):694-698
pubmed: 28750986
Eur Respir J. 2023 Jun 8;61(6):
pubmed: 37024133
Syst Rev. 2022 Jun 13;11(1):121
pubmed: 35698213
Qual Life Res. 2018 May;27(5):1159-1170
pubmed: 29550964
Respirology. 2018 Mar;23(3):284-290
pubmed: 28905471
Qual Life Res. 2018 May;27(5):1171-1179
pubmed: 29260445
J R Soc Med. 1984 Oct;77(10):855-62
pubmed: 6387113
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
Prim Care Respir J. 2005 Apr;14(2):78-82
pubmed: 16701702

Auteurs

Vikram Mohan (V)

Department of Rehabilitation and Sports Sciences, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK.

Chandrasekar Rathinam (C)

University of Birmingham, Birmingham, UK c.rathinam@bham.ac.uk.
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Derick Yates (D)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Aatit Paungmali (A)

Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.

Christopher Boos (C)

Cardiology Department, University Hospitals Dorset NHS Foundation Trust, Poole, UK.
Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH